Back to
WCM INVESTMENT MANAGEMENT, LLC
FATE
Showing 0 of 14 quarters
Position history for
WCM INVESTMENT MANAGEMENT, LLC's holdings in FATE THERAPEUTICS INC
No. WCM Investment Management exited its FATE (Fate Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 185,273 shares worth $1.9M. WCM Investment Management first reported FATE in Q4 2019 and held it in 13 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.